Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

GlycoMimetics doses first patient in Phase III trial of uproleselan

Myeloblasts with Auer rods seen in acute myeloid leukemia, advanced stage. Credit: Paulo Henrique Orlandi Mourao.



  • GlycoMimetics

Go Top